Assuring effective malaria treatment in Africa: Drug efficacy is necessary but not sufficient

Journal of Epidemiology and Community Health

Volumn 59, Issue 3, 2005, Pages 178-179

  Durrheim, D N ^a,b   Williams, H A ^c  

^a JAMES COOK UNIVERSITY   (Australia)

^b Hunter New England Health ^*  (Australia)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISIN; CHLOROQUINE; FANSIDAR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; DRUG EFFICACY; DRUG MARKETING; DRUG RESISTANCE; ECONOMIC ASPECT; EDITORIAL; ENDEMIC DISEASE; GOVERNMENT; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH ECONOMICS; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MEDICAL ETHICS; MORTALITY; PLASMODIUM FALCIPARUM; PREVALENCE; SOCIAL ASPECT; WORLD HEALTH ORGANIZATION;

AFRICA; ANIMALS; ANTIMALARIALS; DELIVERY OF HEALTH CARE; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; TREATMENT OUTCOME;

EID: 14344254956     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.2004.020826     Document Type: Editorial

References (17)

1. Trope JF, Pison G, Preziosi MP, et al. Impact of chloroquine resistance on malaria mortality. Comptes rendes de l'Academie des Sciences. Serie III, Sciences de la vie 1998;321:689-97.
2. Adjuik M, Babiker A, Garner P, et al. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 2004;303:9-17.
3. Durrheim DN, Williams HA, Barnes KI, et al. Beyond evidence: a retrospective study of factors influencing a malaria treatment policy change in two South African Provinces. Critical Public Health 2003;13:309-30.
4. World Health Organisation. WHO Expert Committee on Malaria. Twentieth report. Geneva: WHO, 2000, (http://mosquito.who.int/docs).
5. Sen K, Bonita R. Global health status: two steps forward, one step back. Lancet 2000;356:577-82.
6. Guyatt HL, Ochola SA, Snow RW. Too poor to pay: charging for insecticide-treated beanets in highland Kenya. Trop Med Int Health 2002;7:846-50.
7. Attaran A, Barnes KI, Curtis C, et al. WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet 2004;363:237-40.
8. Nafo-Trooré F. Response to accusations of medical malpractice by WHO and the Global Fund. Lancet 2004;363:397.
9. Nantulya VM, Lidén J. Response to accusations of medical malpractice by WHO and the Global Fund. Lancet 2004;363:397-8.
10. Moerman F, Lengeler C, Chimumbwa J, et al. The contribution of health-care services to a sound and sustainable malaria-control policy. Lancet Infect Dis 2003;3:99-102.
11. Uplekar M, Pathania V, Raviglione M. Private practitioners and public health: weak links in tuberculosis control. Lancet 2001;358:912-16.
12. Sachs J, Malaney P. The economic and social burden of malaria. Nature 2002;415:080-5.
13. Gubler DJ. Human behaviour and cultural context in disease control. Trop Med Int Health 1997;2:A1-54.
14. Williams HA, Kachur PA, Nalwamba CN, et al. A community perspective on the efficacy of malaria treatment options for children in Lundazi District, Zambia. Trop Med Int Health 1997;4:641-52.
15. Logie D. Unfairness of social and economic structures affect AIDS in Africa. BMJ 2002;324:1034.
16. Yamey G. African heads of state promise action against malaria. BMJ 2000;320:1228.
17. Bloland PB, Kachur SP, Williams HA. Trends in antimalarial drug deployment in sub-Saharan Africa. J Exp Biol 2002;206:3761-9.